20:52:36 EST Mon 02 Feb 2026
Enter Symbol
or Name
USA
CA



Hydreight Technologies Inc
Symbol NURS
Shares Issued 49,633,268
Close 2026-02-02 C$ 3.98
Market Cap C$ 197,540,407
Recent Sedar+ Documents

Hydreight estimates 2026 revenue of $150-million

2026-02-02 17:38 ET - News Release

Mr. Shane Madden reports

HYDREIGHT TECHNOLOGIES ISSUES FISCAL 2026 REVENUE GUIDANCE OF = $150 MILLION AND PROVIDES Q1 2026 OUTLOOK

Hydreight Technologies Inc. has issued revenue guidance for the fiscal year ending Dec. 31, 2026, and has provided an outlook for the first quarter of fiscal 2026.

Fiscal 2026 revenue guidance

Based on current internal planning assumptions, the company expects fiscal 2026 revenue of approximately $150-million, representing a conservative baseline outlook reflecting currently contracted demand and visible partner activity.

This guidance is intended to represent a baseline or floor-case scenario and assumes continued execution across the company's existing pharmacy operations and digital health platform. The guidance excludes any potential incremental contributions from acquisitions, new geographic market entries or commercial arrangements that are not currently operational as of the date of this release.

First quarter 2026 revenue outlook

The company expects revenue to increase throughout fiscal 2026 as several major partnerships, clients and pharmacy product lines that were planned and implemented in late 2025 and early 2026 go live. Based on current visibility and contracted activity, the company expects revenue for the first quarter of fiscal 2026 to be in the range of approximately $25-million to $28-million.

Cost structure, margin and profitability context

The company's fiscal 2026 guidance assumes no material increase in fixed operating costs relative to late 2025 levels. Hydreight has already established its national regulatory, pharmacy and technology infrastructure, and management expects incremental revenue growth to be supported largely by this existing cost base.

Based on current internal planning assumptions and assuming fiscal 2026 revenue of approximately $150-million, management expects the company to generate an adjusted earnings before interest, taxes, depreciation and amortization margin of approximately 15 to 17 per cent.

This reflects the anticipated benefit of scaling transaction volumes across a largely fixed operating cost structure. While the company believes it is well positioned to benefit from operating leverage as revenue grows, actual results may vary based on transaction volumes, partner mix, product utilization and other operational factors.

Baseline (floor-case) assumptions

Management defines the $150-million fiscal 2026 guidance as a baseline outlook because it is derived solely from:

  • Existing partner relationships and currently active customer programs;
  • Observable transaction volumes and contracted demand;
  • Continued utilization of the company's existing pharmacy and platform infrastructure.

The guidance does not assume contributions from potential acquisitions, expansion into new international markets or additional enterprise partnerships beyond those already in operation as of the date of this release.

Management commentary

"This guidance reflects the visibility we now have into our operations as we enter 2026," said Shane Madden, chief executive officer of Hydreight. "Importantly, it is grounded in existing demand and supported by a disciplined cost structure. With much of our infrastructure already in place, we believe the business is positioned to scale efficiently while maintaining margin discipline as transaction volumes grow."

Capital position

The company recently completed a $15-million bought deal financing led by Canaccord Genuity Corp. The proceeds provide additional working capital to support anticipated transaction volumes and continuing operations. Management believes the company is adequately capitalized to execute on its fiscal 2026 baseline outlook.

The company thanks its partners, health care professionals, licensees and shareholders for their continued support.

About Hydreight Technologies Inc.

Hydreight is building one of the largest mobile clinic networks in the United States. Its proprietary, fully integrated platform has hosted a network of over 3,000 nurses, over 300 doctors and a pharmacy network through its doctor networks across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking and managing patient data, which enable licensed health care professionals to provide services directly to patients at home, the office or the hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians and other licensed health care professionals. The Hydreight platform allows health care professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states and is closely affiliated with a U.S. certified e-script and telemedicine provider network.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.